• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定急性髓系白血病中的 UBA2-WTIP 融合基因。

Identification of the UBA2-WTIP fusion gene in acute myeloid leukemia.

机构信息

Department of Hematology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province), The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310009, China; Cancer Institute, Zhejiang University, Hangzhou 310009, China.

Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou310009, China.

出版信息

Exp Cell Res. 2018 Oct 15;371(2):409-416. doi: 10.1016/j.yexcr.2018.08.035. Epub 2018 Sep 1.

DOI:10.1016/j.yexcr.2018.08.035
PMID:30179602
Abstract

Identifying and targeting oncogenic fusion genes have revolutionized the treatment of leukemia, such as PML-RARα fusion gene in acute promyelocytic leukemia. Here we identified an intrachromosomal fusion gene located on chromosome 19q.13 between UBA2 and WTIP gene in a case of acute myeloid leukemia. The UBA2-WTIP fusion gene contains the N-terminal E1_enzyme_family, VAE_Ubl domains of UBA2, and the C-terminal LIM domains of WTIP. The UBA2-WTIP fusion was detected by reverse transcriptase polymerase chain reaction and Sanger sequencing in 19 of 56 acute myeloid leukemia samples (33.9%). Ectopic expression of the UBA2-WTIP fusion in human acute myeloid leukemia KG-1a cells showed enhanced cell proliferation both in vitro and in vivo. The UBA2-WTIP fusion induced phosphorylation of STAT3, STAT5 and ERK1/2, and abrogates WTIP-mediated mammalian processing body formation. Finally, triptolide displayed selective cytotoxicity against KG-1a cells harboring the UBA2-WTIP fusion. Collectively, our findings suggest that the UBA2-WTIP fusion is an oncogenic fusion gene, as well as a promising therapeutic target for the treatment of acute myeloid leukemia.

摘要

鉴定和靶向致癌融合基因已经彻底改变了白血病的治疗方法,例如急性早幼粒细胞白血病中的 PML-RARα 融合基因。在这里,我们鉴定了一例急性髓系白血病中位于染色体 19q.13 上 UBA2 和 WTIP 基因之间的染色体内融合基因。UBA2-WTIP 融合基因包含 UBA2 的 N 端 E1_enzyme_family、VAE_Ubl 结构域和 WTIP 的 C 端 LIM 结构域。在 56 例急性髓系白血病样本中的 19 例(33.9%)中通过逆转录聚合酶链反应和 Sanger 测序检测到 UBA2-WTIP 融合。UBA2-WTIP 融合在人急性髓系白血病 KG-1a 细胞中的异位表达显示出体外和体内增强的细胞增殖。UBA2-WTIP 融合诱导 STAT3、STAT5 和 ERK1/2 的磷酸化,并取消 WTIP 介导的哺乳动物加工体形成。最后,雷公藤内酯甲对携带 UBA2-WTIP 融合的 KG-1a 细胞表现出选择性细胞毒性。总之,我们的研究结果表明,UBA2-WTIP 融合是一种致癌融合基因,也是治疗急性髓系白血病的有前途的治疗靶点。

相似文献

1
Identification of the UBA2-WTIP fusion gene in acute myeloid leukemia.鉴定急性髓系白血病中的 UBA2-WTIP 融合基因。
Exp Cell Res. 2018 Oct 15;371(2):409-416. doi: 10.1016/j.yexcr.2018.08.035. Epub 2018 Sep 1.
2
Biologic activity of triptolide in t(8;21) acute myeloid leukemia cells.雷公藤红素在 t(8;21)急性髓系白血病细胞中的生物学活性。
Leuk Res. 2011 Feb;35(2):214-8. doi: 10.1016/j.leukres.2010.07.013. Epub 2010 Aug 6.
3
Low-dose triptolide enhances antitumor effect of JQ1 on acute myeloid leukemia through inhibiting RNA polymerase II in vitro and in vivo.低剂量雷公藤红素通过体外和体内抑制 RNA 聚合酶 II 增强 JQ1 对急性髓系白血病的抗肿瘤作用。
Mol Carcinog. 2020 Sep;59(9):1076-1087. doi: 10.1002/mc.23238. Epub 2020 Jul 21.
4
Cryptotanshinone suppresses key onco-proliferative and drug-resistant pathways of chronic myeloid leukemia by targeting STAT5 and STAT3 phosphorylation.隐丹参酮通过靶向 STAT5 和 STAT3 磷酸化抑制慢性髓性白血病的关键致癌增殖和耐药途径。
Sci China Life Sci. 2018 Sep;61(9):999-1009. doi: 10.1007/s11427-018-9324-y. Epub 2018 Jul 20.
5
Low HOX gene expression in PML-RARα-positive leukemia results from suppressed histone demethylation.HOX 基因低表达导致 PML-RARα 阳性白血病。
Epigenetics. 2018;13(1):73-84. doi: 10.1080/15592294.2017.1413517. Epub 2018 Feb 7.
6
Functional analysis of the two reciprocal fusion genes MLL-NEBL and NEBL-MLL reveal their oncogenic potential.功能分析两个相互融合的基因 MLL-NEBL 和 NEBL-MLL,揭示了它们的致癌潜力。
Cancer Lett. 2013 May 10;332(1):30-4. doi: 10.1016/j.canlet.2012.12.023. Epub 2013 Jan 20.
7
Low dose triptolide reverses chemoresistance in adult acute lymphoblastic leukemia cells via reactive oxygen species generation and DNA damage response disruption.低剂量雷公藤内酯醇通过产生活性氧和破坏DNA损伤反应逆转成人急性淋巴细胞白血病细胞的化疗耐药性。
Oncotarget. 2016 Dec 20;7(51):85515-85528. doi: 10.18632/oncotarget.13454.
8
Extracellular matrix stiffness causes systematic variations in proliferation and chemosensitivity in myeloid leukemias.细胞外基质硬度导致髓系白血病在增殖和化疗敏感性方面出现系统性差异。
Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):12126-12131. doi: 10.1073/pnas.1611338113. Epub 2016 Oct 10.
9
PML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia.PML/RARα调控的miR-181a/b簇靶向急性早幼粒细胞白血病中的肿瘤抑制因子RASSF1A。
Cancer Res. 2015 Aug 15;75(16):3411-24. doi: 10.1158/0008-5472.CAN-14-3521. Epub 2015 Jun 3.
10
WTIP upregulates FOXO3a and induces apoptosis through PUMA in acute myeloid leukemia.WTIP 通过 PUMA 上调 FOXO3a 诱导急性髓系白血病细胞凋亡。
Cell Death Dis. 2021 Dec 20;13(1):18. doi: 10.1038/s41419-021-04467-0.

引用本文的文献

1
Homoharringtonine in the treatment of acute myeloid leukemia: A review.高三尖杉酯碱治疗急性髓系白血病的研究进展。
Medicine (Baltimore). 2024 Nov 1;103(44):e40380. doi: 10.1097/MD.0000000000040380.
2
Natural biomolecules and derivatives as anticancer immunomodulatory agents.天然生物分子及其衍生物作为抗癌免疫调节剂。
Front Immunol. 2023 Jan 9;13:1070367. doi: 10.3389/fimmu.2022.1070367. eCollection 2022.
3
Acute Myeloid Leukemia-Related Proteins Modified by Ubiquitin and Ubiquitin-like Proteins.泛素和类泛素蛋白修饰的急性髓系白血病相关蛋白。
Int J Mol Sci. 2022 Jan 3;23(1):514. doi: 10.3390/ijms23010514.
4
WTIP upregulates FOXO3a and induces apoptosis through PUMA in acute myeloid leukemia.WTIP 通过 PUMA 上调 FOXO3a 诱导急性髓系白血病细胞凋亡。
Cell Death Dis. 2021 Dec 20;13(1):18. doi: 10.1038/s41419-021-04467-0.
5
Pharmacological Modulation of Ubiquitin-Proteasome Pathways in Oncogenic Signaling.致癌信号通路中泛素-蛋白酶体途径的药理学调控
Int J Mol Sci. 2021 Nov 4;22(21):11971. doi: 10.3390/ijms222111971.